BioDetectionSystems

BioDetectionSystems is a partner of the recently established EU-ToxRisk Commercial Platform for New Approach Methods (NAMs) in Safety Assessment

To protect the safety and the quality of our food, health and environment by offering innovative, sensitive and efficient in vitro test methods - that is what BioDetection Systems stands for. 

To this end, we develop tests that quantify biological effects of the compounds and mixtures we are confronted with in our everyday life. In combination with our chemical analytical, and DNA-based techniques, our CALUX® bioassays enable a wide range of applications, such as compliance testing, safety assessments, and biological effect profiling.

With our trained and experienced staff and our well-equipped laboratories, we can be your service provider, your research partner and your consultant.

Latest Tweets

Edelweiss Connect (2 weeks ago)
Prediction of cholestatic potential of drugs and investigation of mechanisms underlying cholestasis #HepaRG #liver… https://t.co/s0Hz1regB5
Edelweiss Connect (4 weeks ago)
New article on HepaRG™ ability to predict drug-cholestatic liability #HepaRG #liver #invitro #DILI… https://t.co/BXaV92exdY
Edelweiss Connect (4 weeks ago)
RT @barryhardy: High throughput prediction of hepatocyte toxicity Signup and abstract for the #SaferWorldbyDesign webinar on this topic w…
Edelweiss Connect (4 weeks ago)
Accurate High-Throughput Prediction of Hepatocyte Toxicity in Humans #SaferWorldbyDesign webinar, Feb 2, 14 CET… https://t.co/z4jxibHRKe
Edelweiss Connect (5 weeks ago)
Tuesday, January 26, 16 CET #SaferWorldbyDesign webinar - Cellenion will present its solutions for single-cell anal… https://t.co/VLjDHCe3VX

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA